MedTrace Logo

Sedation During Spinal Anesthesia

NCT03133780 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2024-02-21

No results posted yet for this study

Summary

Patients during spinal anesthesia should be sedated.

Conditions

  • Sedation During Spinal Anesthesia

Interventions

DRUG

Ketamine

Patient will receive IV ketamine 0.5 mg/kg diluted in normal saline to a volume of 50 ml over 10 min

DRUG

Midazolam

Patient will receive IV midazolam 0.03 mg/kg diluted in normal saline to a volume of 50 ml over 10 min

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Seham M Moeen, MD · Assiut Univerisity

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-14
Primary Completion
2020-03-07
Completion
2020-03-07

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03133780 on ClinicalTrials.gov